Showing results (1521-1530 of 1,729) with videos related to

Sort By:
Pageof 173
Nature Cancer|February 5, 2022
Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasisFlorian Klemm, Aylin Möckl, Anna Salamero-Boix, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2025
Predicting benefit from PARP inhibitors using deep learning on H&E-stained ovarian cancer slidesFrederik Marmé, Eva I Krieghoff-Henning, Lennard Kiehl, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 24, 2024
Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancerAlejandro Perez-Fidalgo, Barbara Schmalfeldt, Angela George, et al.
Acta Neuropathologica|June 25, 2022
Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood-brain barrier in acute ischemic strokeDaniel Spitzer, Sylvaine Guérit, Tim Puetz, et al.
Gynecologic Oncology|January 15, 2019
Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trialMichel Fabbro, Kathleen N Moore, Anne Dørum, et al.
Gynecologic Oncology|September 13, 2020
Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter studyHelmut Plett, Olga T Filippova, Annalisa Garbi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 6, 2021
Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6)Günter Emons, Jae-Weon Kim, Karin Weide, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2021
Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapyAngelina Tjokrowidjaja, Michael Friedlander, Sarah J Lord, et al.
European Radiology|July 18, 2020
Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic featuresSimon Bernatz, Jörg Ackermann, Philipp Mandel, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 18, 2025
Hand Grip Strength Cut-Off Points as a Discriminator of Sarcopenia and Sarcopenic Obesity: Results from the ELSA-Brasil CohortClarice Alves Santos, Helena Fraga Maia, Francisco José Gondim Pitanga, et al.
Pageof 173